Human Trials of New COVID-19 Vaccine Begin

In this episode we speak with Dr Stephen Wright, Consultant in Medicines Development from Limber Strategic, who talks to us about the clinical development of a drug, including how clinical trials are designed and the role of regulatory authorities in the process.

There is a history of unequal access to health care for many groups. In this live panel discussion, Johns Hopkins scientists discuss bias in medicine and address what can be done to give everyone the opportunity to live a healthy life.

In this episode we speak with Professor Paul Brennan from the University of Oxford about lead optimization, what to consider when designing a new drug, and much more.